• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Veterinary/Animal Vaccines Market to grow 9.2% CAGR during the Forecast Period 2023-2032

    Veterinary/Animal Vaccines Market Size to Reach 11.8 billion at 9.2% CAGR by 2032 | MRFR

    Report Details:
    15 Companies Covered
    133 Pages

    Pune, India, March 2022/MRFR Press Release/- Market Research Future has published a cooked research report on the Global Veterinary/Animal Vaccines Market.


    Veterinary/Animal Vaccines Market Report Highlights


    The Veterinary/Animal Vaccines Market is expected to reach 11.8 billion by 2032 at 9.2% CAGR during the forecast period 2023-2032.


    Veterinary vaccines are used to prevent infectious diseases caused by various causing agents and to provide protection to animals from various life-threatening disorders. Majority of the products are used for immunization of companion animals, ruminants, swine, poultry, and aquaculture. Veterinary vaccination has been proved helpful in the prevention of outbreak of livestock diseases.


    An increasing number of pet owners, growing livestock population and disease outbreaks have led to the growth of the global veterinary/animal vaccines market in recent years. However, high storage cost associated with veterinary vaccines is likely to restrain the market growth over the forecast period.


    Market Research Future (MRFR) recognizes the following companies as the key players in the global veterinary/animal vaccines market that includes Boehringer Ingelheim International GmbH (Germany), Zoetis (US), Ceva (US), MSD & Co. Inc (US), Elanco (US), Virbac (France), Phibro Animal Health Corporation (US) Hipra (Spain), IDT Biologika GmbH (Germany), Biogenesis Bago SA (Argentina), and others.

    Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Veterinary/Animal Vaccines Market Research Report

    Segment analysis


    The global veterinary/animal vaccines market has been segmented into type, technology, and region. Based on type, the veterinary/animal vaccines market has been segmented into livestock vaccines, porcine vaccines, companion animal vaccines, poultry vaccines, and aquaculture vaccines. On the basis of technology, the global veterinary/animal vaccines market has been segmented into live attenuated vaccine, inactivated vaccines, recombinant vaccines, and toxoid vaccines.


    Regional Analysis


    Geographically, the Americas is expected to dominate the global veterinary/animal vaccines market. This is owing to the increasing number of pet owners, and growing livestock population and disease outbreaks. Europe showed a considerable amount of growth in the market due to the advances in the technology underlying veterinary vaccines and government & private support. Asia-Pacific is estimated to be the fastest growing region in the market. This is owing to the growing penetration of the veterinary sector, surging number of private veterinary clinics, increasing awareness about animal welfare, and rising non-governmental organizations’ (NGOs) work for the welfare of animals. On the other hand, the Middle East & Africa has the least share of the market.


    Key Findings of the Study:



    • Global veterinary/animal vaccines market is projected to reach USD 9,910.59 million by 2025 with 6.38% CAGR during the review period of 2018 to 2025

    • Americas accounted for the largest share due to in the region

    • The livestock vaccines segment is accounted for the largest share, holding a market value of USD 1,558.94 in 2017.

    • Some of the players operating in the veterinary/animal vaccines market are Boehringer Ingelheim International GmbH, Zoetis, Ceva, MSD & Co. Inc., Elanco among others. 


    This research report provides the insights, on various levels of analyses such as industry analysis, market share analysis leading market players and their profiles. This report also helps in studying the target segments by providing views on emerging & high-growth segments and market conclusion. Together the market data comprise and discuss with the basic assessments on the competitive scenarios & strategies, of the Global Veterinary/Animal Vaccines Market, including the high-growth regions and their political, economic and technological environments. Furthermore, the project report also provides the views over the historical market values as well as, pricing and cost analysis of the same.

    Related Reports